CAS NO: | 1801342-60-8 |
包装 | 价格(元) |
1mg | 电议 |
5mg | 电议 |
生物活性 | Cemiplimab (Anti-Human PD-1) is a high-affinity programmed death receptor-1 (PD-1) monoclonalIgG4antibody that blocks PD-1/PD-L1-mediated T-cell suppression. Cemiplimab is commonly used in squamous cell skincancerresearch[1][2]. | ||||||||
体内研究 (In Vivo) | Cemiplimab (i.p., 10 mg/kg, five injections within 2 weeks) can increased the proportion of effector T cells in tumors and dLNs to reduce tumor growth by combined immunotherapy with REGN3767 in MC38.Ova tumor mice model[2].
| ||||||||
Clinical Trial | |||||||||
CAS 号 | 1801342-60-8 | ||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |